|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0970 AUD | +15.48% |
|
+19.75% | +14.12% |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | A$0.39 | +364.29% | 1 | ||||
| $1,110.72 | +2.15% | 28 | ||||||
| $222.25 | +1.72% | 24 | ||||||
| $245.22 | +12.43% | 27 | ||||||
| CHF 342.27 | -1.62% | 19 | ||||||
| GBX 204.34 | +11.68% | 20 | ||||||
| CHF 140.84 | -3.28% | 20 | ||||||
| DKK 404.99 | +2.09% | 21 | ||||||
| $115.11 | +5.43% | 27 | ||||||
| $331.59 | -4.46% | 27 | ||||||
| $134.53 | +2.59% | 26 | ||||||
| $28.66 | +9.8% | 24 | ||||||
| $506.24 | +8.32% | 25 | ||||||
| €100.96 | +26.58% | 22 | ||||||
| $56.96 | +3.67% | 23 | ||||||
| GBX 18.73 | +3.78% | 19 | ||||||
| JP¥8,892.86 | +5.87% | 14 | ||||||
| CN¥82.86 | +39.4% | 17 | ||||||
| €40.98 | -7.22% | 20 | ||||||
| Average | 683.18 | +25.43% | 21 | ||||||
| Weighted average by Cap. | 579.83 | +4.40% | 24 |
- Stock Market
- Equities
- NUZ Stock
- Sector Neurizon Therapeutics Limited
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition